Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      10:45 - 10:45  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...

    • +

      Session Moderator

      10:45 - 10:45  |  Presenter: Rafael Rosell

      • Abstract

      Loading...

    • +

      MA02.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...

    • +

      MA02.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Rafael Rosell

      • Abstract

      Loading...

    • +

      MA02.03 - The Evolution of Lung Neuroendocrine Tumors

      10:47 - 10:52  |  Presenter: Nicolas Alcala

      • Abstract

      Loading...

    • +

      MA02.04 - Molecular Drivers and Therapeutic Targets for Neuroendocrine Transformation in Lung Cancer

      10:52 - 10:57  |  Presenter: Triparna Sen

      • Abstract

      Loading...

    • +

      MA02.05 - Dynamic Mutation Profiles of SCLC Transformation in NSCLC Patients Harboring Concurrent EGFR/TP53/RB1 Mutations

      10:57 - 11:02  |  Presenter: Jie Huang

      • Abstract

      Loading...

    • +

      MA02.06 - Discussant

      11:02 - 11:12  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      MA02.07 - Aurora A Kinase Inhibition with VIC-1911Potentiates KRASG12C Inhibitor and Overcomes Resistance to Sotorasib in Lung Cancer

      11:12 - 11:17  |  Presenter: Jong Woo Lee

      • Abstract

      Loading...

    • +

      MA02.08 - Trametinib Inhibition of MEK1 2 Upregulates PD-L1 Expression in KRAS-Mutant NSCLC Through ID1 Downregulation

      11:17 - 11:22  |  Presenter: Ander Puyalto

      • Abstract

      Loading...

    • +

      MA02.09 - Impact of Baseline Clinicopathologic and Genomic Features on Outcomes to KRAS G12C Inhibitors in Patients with NSCLC

      11:22 - 11:27  |  Presenter: Giuseppe Lamberti

      • Abstract

      Loading...

    • +

      MA02.10 - Discussant

      11:27 - 11:37  |  Presenter: Sally Lau

      • Abstract

      Loading...

    • +

      MA02.11 - Live Q&A

      11:37 - 11:45

      • Abstract

      Loading...

  • +

    MA12 - Pathology: Tumour Diagnostics

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Pathology
    • +

      MA12.07 - Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma With Lepidic Growth

      11:12 - 11:17  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...

    • +

      MA12.08 - Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

      11:17 - 11:22  |  Presenter: Federica Filipello

      • Abstract

      Loading...